Segment disclosures

Company overview

바이오다인

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 9 retained observations 7 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Consolidated

Consolidated And Separate Financial Statements

Source dimensions ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30587322126 KRW20261012Open filing evidence
2026-01-01 – 2026-06-301454424710 KRW20261012Open filing evidence
2026-01-01 – 2026-03-31867102584 KRW20260515Open filing evidence
2025-01-01 – 2025-12-317027675925 KRW20260313Open filing evidence
2025-04-01 – 2025-06-301791363876 KRW20261012Open filing evidence
2025-01-01 – 2025-06-302707959955 KRW20261012Open filing evidence
2025-01-01 – 2025-03-31916596079 KRW20260515Open filing evidence
2024-01-01 – 2024-12-315271365360 KRW20260313Open filing evidence
2023-01-01 – 2023-12-314088693758 KRW20260313Open filing evidence